This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://dx.doi.org/10.5152/
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q91302408
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel im Dezember 2017 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'avientu de 2017 наукова стаття, опублікована в грудні 2017 scientific article published on 07 December 2017
p:P577
wds:Q91302408-18B50CA9-5561-41C7-BBD8-F1EE716A7484
wdt:P577
2017-12-07T00:00:00Z
p:P2093
wds:Q91302408-ECE55DFE-F95C-4853-98EF-EF647E531B8D wds:Q91302408-553F5848-4A81-4132-9F2E-D50788EAF7A8 wds:Q91302408-35E0EC3A-79C0-41C0-B562-1DC356190AA4
wdt:P2093
Phoebe Prowse Gelareh Farshid Barbara True
rdfs:label
Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis
skos:prefLabel
Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis
schema:name
Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis
p:P1476
wds:Q91302408-CB72C72C-4745-4696-9E37-EB1DDF9B96E2
wdt:P1476
Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis
p:P304
wds:Q91302408-A6A82B9A-A3C2-4E67-A9A4-E7456FC4000B
wdt:P304
131-134
p:P31
wds:Q91302408-6e059a23-dab3-48a3-89c1-925fe859bdaf wds:Q91302408-78B6BACE-CE58-41E3-9E63-C9EB6AAE33A4
wdt:P31
wd:Q2782326 wd:Q13442814
p:P921
wds:Q91302408-21DC740D-4439-4823-B540-49DC54AB379C wds:Q91302408-718B5D2B-DA16-4AD5-9AB3-CF916567FE88
wdt:P921
wd:Q348260 wd:Q53907631
p:P698
wds:Q91302408-35B38CD7-5AA3-4F66-989B-7508E8BE947A
wdtn:P698
n12:30185362
wdt:P698
30185362
p:P1433
wds:Q91302408-12AAB432-FDA2-494E-9027-2A41FA4CAE37
wdt:P1433
wd:Q27727583
p:P433
wds:Q91302408-FB7D88D9-4FC0-4C40-9D7E-E784040BA872
p:P478
wds:Q91302408-944B28EF-458E-43FA-87C8-4374985C246D
wdt:P433
2
wdt:P478
5
p:P356
wds:Q91302408-16993E14-DE50-4132-B2E4-AB947189DB4D
wdtn:P356
n10:EURJRHEUM.2017.17083
wdt:P356
10.5152/EURJRHEUM.2017.17083
p:P932
wds:Q91302408-F1254FD6-CA19-4B7C-902A-1BBAA7754B81
wdt:P932
6072696